Bill Texts: MD HB666 | 2017 | Regular Session

Bill Title: Public Health - Expensive Drugs - Manufacturer Reporting and Drug Price Transparency Advisory Committee

Sponsorship: Partisan Bill (Democrat 74)

Status: (Introduced - Dead) 2017-02-23 - Hearing 2/23 at 1:00 p.m. [HB666 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2017-02-01PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Maryland HB666

Supplemental Documents

TitleDescriptionDateFormatSourceView
AnalysisFiscal Note/AnalysisNot AvailPDFLinkView

feedback